APP and Alzheimer disease: Elevated CRMP2 phosphorylation has been observed in postmortem AD brains [11,12,13,14,15] and in transgenic mouse models including APP/PS1 and Tg2576 [13,15,16,64], suggesting its involvement in early AD events [13].